JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Psychedelic drugs: the ups and downs of ecstasy.

Nature May 1, 2004 DOI: 10.1038/429126a (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	News report Peer reviewed
Topics	MDMA
Key points	The report highlights that MDMA and other psychedelics show promise in treating conditions like PTSD and depression, but also carry risks of adverse effects and potential for misuse, necessitating cautious clinical application and further research.

Abstract

Psychedelic drugs: the ups and downs of ecstasy.

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research Human Psychopharmacology Clinical and Experimental December 1, 2001 349 citations
Snowbound Meet Me with Your Black Drawers On December 31, 2006
Psychedelic trials face downsides of the 'trip'. Science (New York, N.Y.) March 7, 2025
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. Journal of psychopharmacology (Oxford, England) September 1, 2006 117 citations
The varieties of ecstasy experience: a phenomenological ethnography. Journal of Psychoactive Drugs 2013 6 citations